Follow
Mohammad Shahrokh Esfahani
Mohammad Shahrokh Esfahani
Other namesMohammad S Esfahani
Assistant Professor of Radiation Oncology, Stanford University
Verified email at stanford.edu - Homepage
Title
Cited by
Cited by
Year
Determining cell type abundance and expression from bulk tissues with digital cytometry
AM Newman, CB Steen, CL Liu, AJ Gentles, AA Chaudhuri, F Scherer, ...
Nature Biotechnology 37 (7), 773-782, 2019
25182019
Early detection of molecular residual disease in localized lung cancer by circulating tumor DNA profiling
AA Chaudhuri, JJ Chabon, AF Lovejoy, AM Newman, H Stehr, TD Azad, ...
Cancer Discovery 7 (12), 1394-1403, 2017
7722017
Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients
JJ Chabon, AD Simmons, AF Lovejoy, MS Esfahani, AM Newman, ...
Nature Communications 7 (1), 1-15, 2016
6052016
Integrating genomic features for non-invasive early lung cancer detection
JJ Chabon*, EG Hamilton*, DM Kurtz*, MS Esfahani* (Co-First), ...
Nature, 1-7, 2020
4452020
Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA
F Scherer, DM Kurtz, AM Newman, H Stehr, AFM Craig, MS Esfahani, ...
Science Translational Medicine 8 (364), 364ra155-364ra155, 2016
4272016
Circulating tumor DNA measurements as early outcome predictors in diffuse large B-cell lymphoma
DM Kurtz, F Scherer, MC Jin, J Soo, AFM Craig, MS Esfahani, JJ Chabon, ...
Journal of Clinical Oncology 36 (28), 2845, 2018
3802018
Noninvasive Early Identification of Therapeutic Benefit from Immune Checkpoint Inhibition
BY Nabet*, MS Esfahani* (Co-First), EJ Moding, EG Hamilton, JJ Chabon, ...
Cell, 2020
2412020
Circulating tumor DNA analysis for detection of minimal residual disease after chemoradiotherapy for localized esophageal cancer
TD Azad, AA Chaudhuri, P Fang, Y Qiao, MS Esfahani, JJ Chabon, ...
Gastroenterology 158 (3), 494-505. e6, 2020
1692020
Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA
DM Kurtz, J Soo, L Co Ting Keh, S Alig, JJ Chabon, BJ Sworder, A Schultz, ...
Nature Biotechnology 39 (12), 1537-1547, 2021
1642021
Dynamic Risk Profiling Using Serial Tumor Biomarkers for Personalized Outcome Prediction
DM Kurtz*, MS Esfahani*, F Scherer* (Co-First), J Soo, MC Jin, CL Liu, ...
Cell, 2019
1622019
Effect of separate sampling on classification accuracy
M Shahrokh Esfahani, ER Dougherty
Bioinformatics, btt662, 2013
1582013
Detection and surveillance of bladder cancer using urine tumor DNA
JC Dudley, J Schroers-Martin, DV Lazzareschi, WY Shi, SB Chen, ...
Cancer discovery 9 (4), 500-509, 2019
1562019
The landscape of tumor cell states and ecosystems in diffuse large B cell lymphoma
CB Steen, BA Luca, MS Esfahani, A Azizi, BJ Sworder, BY Nabet, ...
Cancer cell 39 (10), 1422-1437. e10, 2021
1172021
Inferring gene expression from cell-free DNA fragmentation profiles
MS Esfahani, EG Hamilton, M Mehrmohamadi, BY Nabet, SK Alig, ...
Nature biotechnology 40 (4), 585-597, 2022
732022
Intrinsically Bayesian robust Kalman filter: An innovation process approach
R Dehghannasiri, MS Esfahani, ER Dougherty
IEEE Transactions on Signal Processing 65 (10), 2531-2546, 2017
492017
Determinants of resistance to engineered T cell therapies targeting CD19 in large B cell lymphomas
BJ Sworder, DM Kurtz, SK Alig, MJ Frank, N Shukla, A Garofalo, ...
Cancer Cell 41 (1), 210-225. e5, 2023
462023
Incorporation of Biological Pathway Knowledge in the Construction of Priors for Optimal Bayesian Classification
M Shahrokh Esfahani, E Dougherty
IEEE/ACM Transactions on Computational Biology and Bioinformatics, 1-1, 2013
44*2013
Incorporating biological prior knowledge for Bayesian learning via maximal knowledge-driven information priors
S Boluki, MS Esfahani, X Qian, ER Dougherty
BMC bioinformatics 18, 61-80, 2017
432017
Short diagnosis-to-treatment interval is associated with higher circulating tumor DNA levels in diffuse large B-cell lymphoma
S Alig, CW Macaulay, DM Kurtz, U Dührsen, A Hüttmann, C Schmitz, ...
Journal of Clinical Oncology 39 (23), 2605, 2021
402021
Functional significance of U2AF1 S34F mutations in lung adenocarcinomas
MS Esfahani, LJ Lee, YJ Jeon, RA Flynn, H Stehr, AB Hui, N Ishisoko, ...
Nature Communications 10 (1), 1-13, 2019
352019
The system can't perform the operation now. Try again later.
Articles 1–20